Regenxbio
RGNX
167 hedge funds and large institutions have $742M invested in Regenxbio in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 63 increasing their positions, 58 reducing their positions, and 23 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
121% more call options, than puts
Call options by funds: $4.66M | Put options by funds: $2.11M
5% more capital invested
Capital invested by funds: $705M → $742M (+$36.6M)
9% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 58
0.34% more ownership
Funds ownership: 85.06% → 85.4% (+0.34%)
4% less funds holding
Funds holding: 174 → 167 (-7)
30% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SGL
Sonic GP LLC
Honolulu,
Hawaii
|
+$10.6M |
| 2 |
WM
WS Management
Jacksonville,
Florida
|
+$7.68M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$7.43M |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$7.39M |
| 5 |
BlackRock
New York
|
+$4.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$9.92M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$6.93M |
| 3 |
JP Morgan Chase
New York
|
-$5.86M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$5.78M |
| 5 |
MFS
Mirabella Financial Services
London,
United Kingdom
|
-$5.46M |
RGNX Hedge Fund Activity: Q2 2023 in Review
167 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q2 2023, worth a combined $742M — up 5.2% from $705M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of RGNX and 16 opened new positions — a net loss of 7 holders — while 58 trimmed existing stakes and 63 added.
The largest buyer was Sonic GP LLC, adding an estimated $10.6M. The largest seller was Millennium Management, cutting an estimated $9.92M.
- 167 institutional investors held Regenxbio (RGNX) as of Q2 2023, down from 174 in Q1 2023.
- Funds reported $742M of Regenxbio stock for Q2 2023, up 5.2% quarter-over-quarter.
- 16 funds opened new Regenxbio positions in Q2 2023 and 23 closed out, a net change of -7 holders.
- The largest Regenxbio buyer in Q2 2023 was Sonic GP LLC, an estimated $10.6M added.
- The largest Regenxbio seller in Q2 2023 was Millennium Management, an estimated $9.92M sold.
Based on aggregated 13F filings for Q2 2023.